These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 5563790

  • 1. [A comparative study of the effect of bradykinin, kallidin, methionyl-lysyl-badykinin and eledoisin on skin vessel permeability].
    Gaponiuk PIa, Oĭvin VI.
    Biull Eksp Biol Med; 1971 Mar; 71(3):57-9. PubMed ID: 5563790
    [No Abstract] [Full Text] [Related]

  • 2. Comparative influence of the Ca-ionophore A 23187, bradykinin, kallidin and eledoisin on the rabbit pulmonary vasculature with special reference to arachidonate metabolism.
    Seeger W, Neuhof H, Graubert E, Wolf H, Roka L.
    Adv Exp Med Biol; 1983 Mar; 156():533-51. PubMed ID: 6407283
    [Abstract] [Full Text] [Related]

  • 3. The effect of bradykinin, kallidin and eledoisin upon the pulmonary vascular bed of an isolated blood-perfused rabbit lung preparation.
    Hauge A, Lunde PK, Waaler BA.
    Acta Physiol Scand; 1966 Mar; 66(3):269-77. PubMed ID: 5917803
    [No Abstract] [Full Text] [Related]

  • 4. [Polypeptides (bradykinin, kallidin, eledoison) and the movement of intestinal villi].
    Ludány G, Ihász M, Karika J.
    Acta Physiol Acad Sci Hung; 1968 Mar; 34(1):85-93. PubMed ID: 5705056
    [No Abstract] [Full Text] [Related]

  • 5. Hypotensive peptides: bradykinin, kallidin, and eledoisin.
    Erdös EG.
    Adv Pharmacol (1962); 1966 Mar; 4():1-90. PubMed ID: 5333768
    [No Abstract] [Full Text] [Related]

  • 6. A comparison in conscious and anaesthetized dogs of the effect on blood pressure of bradykinin, kallidin, eledoisin and kallikrein.
    Pearson L, Lang WJ.
    Eur J Pharmacol; 1967 Nov; 2(2):83-7. PubMed ID: 5583434
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. On the potentiation of kinins by sulfhydrylic compounds.
    Auerswald W, Doleschel W.
    Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):188-98. PubMed ID: 4292761
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A comparison of the effects of locally and systemically administered kinins on coronary blood flow and myocardial metabolism.
    Lochner W, Parratt JR.
    Br J Pharmacol Chemother; 1966 Jan; 26(1):17-26. PubMed ID: 5919501
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A perfused vein preparation sensitive to plasma kinins.
    Horowitz JD, Mashford ML.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969 Jan; 263(2):332-9. PubMed ID: 4305806
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.